Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Host vs Graft Reaction”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Testing effectiveness (Phase 2)Study completedNCT02133924
What this trial is testing

Multicenter Study Of Natalizumab Plus Standard Steroid Treatment For High Risk Acute Graft-Versus-Host Disease

Who this might be right for
Acute Graft Versus Host Disease
John Levine 76
Large-scale testing (Phase 3)Study completedNCT00717678
What this trial is testing

Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney TransplantationTransplantation ImmunologyHost vs Graft Reaction
Astellas Pharma Inc 73
Large-scale testing (Phase 3)Study completedNCT00720408
What this trial is testing

Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Liver Transplant Recipients.

Who this might be right for
Liver TransplantationTransplantation ImmunologyHost vs Graft Reaction
Astellas Pharma Inc 48
Testing effectiveness (Phase 2)UnknownNCT04969172
What this trial is testing

A Phase II Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Exosomes Overexpressing CD24 to Prevent Clinical Deterioration in Patients With Moderate or Severe COVID-19 Infection

Who this might be right for
COVID-19 Disease
Eli Sprecher, MD 155
Large-scale testing (Phase 3)UnknownNCT03371667
What this trial is testing

To Compare the Efficacy of the Addition of Methotrexate (MTX) to Current Standard Acute Graft-versus-host Disease (GVHD) First-line Treatment With Corticosteroids

Who this might be right for
Allogeneic DiseaseGVH - Graft Versus Host ReactionGVHD, Acute+1 more
Assistance Publique - Hôpitaux de Paris 102
Not applicableLooking for participantsNCT05992272
What this trial is testing

Cue Effects in Human Addiction: Pavlovian to Instrumental Transfer

Who this might be right for
Alcohol Use Disorder (AUD)AlcoholismSubstance Use Disorders+3 more
Charite University, Berlin, Germany 300
Testing effectiveness (Phase 2)UnknownNCT01423708
What this trial is testing

Everolimus in de Novo Liver Transplantation: a Multicentre Randomized Study

Who this might be right for
Liver FailureLiver DiseasesLiver Cirrhosis+1 more
Azienda Ospedaliera di Padova 117
Not applicableUnknownNCT00427024
What this trial is testing

Renal Transporters After Renal Transplantation

Who this might be right for
Kidney TransplantationHost vs Graft Reaction
University Hospital Muenster 200
Large-scale testing (Phase 3)UnknownNCT05158608
What this trial is testing

Comparison of PT-Cy at a Dose of 25 mg/kg/Day and PT-Cy at a Dose of 50 mg/kg/Day in GVHD Prophylaxis

Who this might be right for
Graft Versus Host DiseaseHematologic MalignancyCyclophosphamide Adverse Reaction
National Research Center for Hematology, Russia 100
Not applicableNo Longer AvailableNCT03172455
What this trial is testing

Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Acute-graft-versus-host DiseaseSteroid Refractory Acute Graft Versus Host DiseaseGraft-versus-host-disease+5 more
Impatients N.V. trading as myTomorrows